Enhancement of erythropoiesis by erythropoietin, bovine protein and energy fortified mother's milk during anaemia of prematurity
Autor: | A Rønnestad, P. J. Moe, N Breivik |
---|---|
Rok vydání: | 1995 |
Předmět: |
medicine.medical_specialty
Diet therapy Anemia Radioimmunoassay Infant Premature Diseases Breast milk Placebo Placebos Electrolytes Double-Blind Method Internal medicine medicine Animals Humans Erythropoiesis Erythropoietin Analysis of Variance Milk Human business.industry Infant Newborn Gestational age General Medicine Iron deficiency Milk Proteins medicine.disease Endocrinology Food Fortified Pediatrics Perinatology and Child Health Cattle business medicine.drug |
Zdroj: | Acta Paediatrica. 84:809-811 |
ISSN: | 1651-2227 0803-5253 |
DOI: | 10.1111/j.1651-2227.1995.tb13762.x |
Popis: | Twenty-four premature infants, < 32 weeks gestational age, were randomly assigned in a double-blind, placebo-controlled trial to 6 weeks of treatment with either recombinant human erythropoietin (rHuEpo) 150 U/kg three times per week given sc (n = 12) or placebo (n = 12). The infants were fed a diet rich in protein (3.2 g/kg/day) and energy (130 kcal/kg/day) based on their own mother's milk fortified with bovine protein together with moderate iron supplementation (4 mg/kg/day). During the treatment (rHuEpo versus placebo) significant differences in mean (+/- SD) reticulocyte count (4.8 +/- 1.2 versus 2.7 +/- 1.4%; p < 0.01), mean packed red cell volume (PCV) (0.38 +/- 0.03 versus 0.34 +/- 0.04, p < 0.05) and mean haemoglobin concentration (12.6 +/- 1.1 versus 11.5 +/- 1.2 g/100 ml; p < 0.05) were found. Within the rHuEpo group, PCV and haemoglobin concentration remained unaltered from entry to 1 week after cessation of treatment whereas a significant decline was observed in the placebo group. No indications of iron deficiency were seen. We conclude that moderate doses of rHuEpo given to infants fed a diet rich in protein and energy are effective in ameliorating anaemia of prematurity. High iron supplementation does not seem to be essential for a significant erythropoietic response. No adverse effect attributable to rHuEpo was observed. |
Databáze: | OpenAIRE |
Externí odkaz: |